SãoPaulo 2010 3 É expressamente proibida a comercialização deste documento tanto na sua forma impressa como eletrônica. Sua reprodução total ou parcial é permitida exclusivamente para fins acadêmicos e científicos, desde que na reprodução figure a identificação do autor, título, instituição e ano da tese/dissertação. 4 DEDICATÓRIA Ao meu filho Vinicius por entender minha ausência, tanto física, quanto psicológica, durante essa longa jornada. Você justifica qualquer esforço.
ABSTRACTThe Brazilian National Health System (SUS) is responsible for the incorporation of many health technologies, and thus, it could be having an indirect function in the scientific production that has not been considered as one of its qualities. Objective:to evaluate if the technologies incorporation by SUS is associated with an increment in national scientific production about those technologies. Material and methods:This is a descriptive study where it was selected some medications (pharmacologic technologies) that are offered by SUS. The PubMed database was used for the search of Brazilian and other countries scientific production about these technologies. TheBrazilian international ranking position in the 3 years before SUS incorporation was compared with the position in the 4 th , 5 th and 6 th years after the incorporation.Wilcoxon nonparametric test was used to perform this comparison. Results: the Brazilian international ranking position improves for 70 of the 90 technologies evaluated. The mean Brazilian ranking position went from 68 th to 45 th after incorporation (p < 0.0001). Conclusion: the incorporation of pharmacologic technologies by SUS is associated with an increment in the national knowledge production about these technologies.